Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bifonazole, a biochemist's view.

D Berg, M Plempel

    Dermatologica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Bifonazole offers a dual-action approach to fungal infections by inhibiting sterol biosynthesis and HMG-CoA-reductase. This broad-spectrum antimycotic demonstrates pathogen-specific action and pH-dependent efficacy against fungi like Candida albicans.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ballet and how it can improve neuromuscular function with age.

    Journal of neurophysiology·2025
    Same author

    Transcranial direct current stimulation of the right temporoparietal junction facilitates hippocampal spatial learning in Alzheimer's disease and mild cognitive impairment.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2023
    Same author

    Health Service Delivery and Economic Evaluation of Limb Lower Bone-Anchored Prostheses: A Summary of the Queensland Artificial Limb Service's Experience.

    Canadian prosthetics & orthotics journal·2023
    Same author

    [Immune-mediated encephalomyelitis].

    Der Nervenarzt·2021
    Same author

    [Spastic paresis of the arms and flaccid paralysis of the legs in secondary progressive multiple sclerosis].

    Der Nervenarzt·2021
    Same author

    Disease modifying treatment trials in Parkinson's disease: how to balance expectations and interests of patients, physicians and industry partners?

    Neurological research and practice·2020
    Same journal

    Radiodermatitis with late ulcer (sarcoma) for 34 years.

    Dermatologica·2010
    Same journal

    Alopecia decalvans, totalis, maligna, with nail changes and tooth abnormalities.

    Dermatologica·2010
    Same journal

    Epidermolysis bullosa tarda simplex.

    Dermatologica·2010
    Same journal

    Blistering after psychological arousal.

    Dermatologica·2010
    Same journal

    Mycosis fungoides in the tumor stage.

    Dermatologica·2010
    Same journal

    Photoallergic rash after Irgafen.

    Dermatologica·2010
    See all related articles

    Area of Science:

    • Biochemistry
    • Mycology
    • Pharmacology

    Background:

    • Bifonazole is a broad-spectrum antimycotic agent.
    • Antimycotics often target sterol biosynthesis pathways in fungi.
    • Understanding the precise mechanism of action is crucial for drug development.

    Purpose of the Study:

    • To elucidate the detailed mechanism of action of bifonazole.
    • To compare the action of bifonazole with clotrimazole.
    • To investigate the pH-dependent efficacy and uptake of bifonazole.

    Main Methods:

    • Enzyme inhibition assays to study HMG-CoA-reductase and cytochrome P450 activity.
    • In vitro studies on fungal pathogens, including Candida albicans and dermatophytes.
    • Measurement of intracellular drug concentrations and assessment of cellular damage.

    Related Experiment Videos

    Main Results:

    • Bifonazole inhibits both cytochrome P450-dependent C14-demethylation and directly HMG-CoA-reductase in dermatophytes.
    • Unlike clotrimazole, bifonazole's inhibition of HMG-CoA-reductase is direct and pathogen-specific.
    • Bifonazole's efficacy is pH-dependent, linked to intracellular drug concentration, and sublethal doses damage Candida albicans cells.

    Conclusions:

    • Bifonazole exhibits a sequential, dual mode of action against fungal sterol biosynthesis.
    • The direct inhibition of HMG-CoA-reductase by bifonazole is a key differentiator from clotrimazole.
    • pH-dependent uptake and cellular damage contribute to bifonazole's antimycotic activity, particularly against Candida albicans.